Open Science Slovenia
New in RUL
The use of polymer chitosan in intravesical treatment of urinary bladder cancer and infections
PDF - Presentation file,
URL - Source URL, Visit
The most frequent diseases of the urinary bladder are bacterial infections and bladder cancers. For both diseases, very high recurrence rates are characteristic: 50-80% for bladder cancer and more than 50% for bladder infections, causing loss of millions of dollars per year for medical treatment and sick leave. Despite years of searching for better treatment, the prevalence of bladder infections and bladder cancer remains unchanged and is even increasing in recent years. Very encouraging results in treatment of both diseases recently culminated from studies combining biopolymer chitosan with immunotherapy, and chitosan with antibiotics for treatment of bladder cancer and cystitis, respectably. In both pathways of research, the discoveries involving chitosan reached a successful long-lasting cure. The property of chitosan that boosted the effectivity of illness-specific drugs is its ability to enhance the accessibility of these drugs to the very sources of both pathologies that individual treatments without chitosan failed to achieve. Chitosan can thus be recognised as a very promising co-player in treatment of bladder cancer and bacterial cystitis.
1.02 - Review Article
MF - Faculty of Medicine
Number of pages:
Vol. 10, iss. 3, art. 265
ISSN on article:
V datoteki založnikove različice članka (PDF) je navedena napačna številka članka (625). Prava številka članka (265) je navedena na pristajalni strani članka (URL). (Datum opombe: 28. 7. 2021)
Voting is allowed only to
Cite this work
Record is a part of a journal
Molecular Diversity Preservation International
Document is financed by a project
ARRS - Agencija za raziskovalno dejavnost Republike Slovenije (ARRS)
Diferenciacija urotelijskih celic
CC BY 4.0, Creative Commons Attribution 4.0 International
This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:
Similar works from RUL:
Similar works from other Slovenian collections:
You have to
to leave a comment.
0 - 0 / 0
There are no comments!